Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03846947 · ClinicalTrials.gov registry record · NA
Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03846947 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 28 participants.
The verdict
NCT03846947, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate potential clinical efficacy of a novel magnetic resonance imaging (MRI) approach, MR fingerprinting, capable of providing quantitative measures of important tissue properties, which could provide important insights into normal breast tissue. This new MRI sequence will be added to the screening breast Dynamic Contrast Enhanced (DCE) MRI for high risk normal patients.
Interventions
- DEVICE MR Fingerprinting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2019-02-18 |
| Est. Completion | 2022-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03846947
The ClinicalTrials.gov registry entry for NCT03846947 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MR Fingerprinting is the first listed.
NCT03846947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03846947 about?
NCT03846947 is a clinical study titled "Novel MRI Sequence MR Fingerprinting in Breast MRI Feasibility Study". The purpose of this study is to evaluate potential clinical efficacy of a novel magnetic resonance imaging (MRI) approach, MR fingerprinting, capable of providing quantitative measures of important tissue properties, which could provide important insights into normal breast tissue. This new MRI sequ...
What is the current status of trial NCT03846947?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2019-02-18. Estimated completion is 2022-06-21.
What interventions are being tested in trial NCT03846947?
The interventions under investigation include: MR Fingerprinting (DEVICE).
Who is sponsoring clinical trial NCT03846947?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.